mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-06 |
mRNA |
SB52334 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
2e-05 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-05 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |